Transgenic plants created for oral immunization against diarrheal diseases

Journal of Travel Medicine

Volumn 3, Issue 1, 1996, Pages 52-56

  Richter, Liz ^a   Mason, Hugh S ^a   Arntzen, Charles J ^a  

^a United States Department of Agriculture Agricultural Research Service and Boyce Thompson Institute for Plant Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1942531480     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1708-8305.1996.tb00697.x     Document Type: Review

References (27)

1. Okhuysen PC, Ericsson CD. Travelers' diarrhea. Prevention and treatment. Med Clin North Am 1992; 76:1357-1373.
2. Svennerholm A-M, Holmgren J. Oral combined B subunit - whole cell cholera vaccine. In: Holmgren J, Lindberg A, Mollby R, eds. Development of vaccines and drugs against diarrhea: Eleventh Nobel Conference, 1985. Stockholm: Robert E. Krieger Publishing, 1986:33-43.
3. Hol WGJ, Sixma TK, Merritt EA. Structure and function of E. coli heat-labile enterotoxin and cholera toxin B pentamer. In: Moss J, Iglewski B.Vaughan M, Tu AT, eds. Bacterial toxins and virulence factors in disease. Handbook of natural toxins.Vol 8. New York: Marcel Dekker, 1995:185-223.
4. Glass RI, Gentsch J, Smith JC. Rotavirus vaccines: success by reassortment? Science 1994; 265:1389-1391.
5. DeZoysa I, Feachem RG. Interventions for the control of diarrhoeal diseases among young children: rotavirus and cholera immunization. Bull World Health Organ 1985; 63:569-583.
6. Offit PA, Coupar BEH, Svoboda YM, et al. Induction of rotavirus-specific cytotoxic T lymphocytes by Vaccinia virus recombinants expressing individual rotavirus genes. Virology 1994; 198:10-16.
7. Jiang X, Graham DY, Wang KN, Estes MK. Norwalk virus genome cloning and characterization. Science 1990; 250:1580-1583.
8. Kaplan JE, Feldman R, Campbell DS, Lookabaugh C et al. The frequency of a Norwalk-like pattern of illness in outbreaks of acute gastroenteritis. Am J Public Health 1982; 72: 1329-1332.
9. Ball JM, Estes MK, Hardy ME, et al. Recombinant Norwalk virus-like particles as an oral vaccine. Arch Virol 1996; in press.
10. Holmgren J, Lycke N, Czerkinsky C. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine 1993; 11:1179-1184.
11. De Aizpurua HJ, Russell-Jones GJ. Oral vaccination: identification of classes of proteins that provoke an immune response upon oral feeding. J Exp Med 1988; 167:440-451.
12. Haq TA, Mason HS, Clemens JD, Arntzen C. Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science 1995; 268:714-716.
13. Mason HS, Arntzen CJ. Transgenic plants as vaccine production systems. Trends Biotechnol 1995; 13;388-392.
14. Hiatt A, Cafferkey R, Bowdish K. Production of antibodies in transgenic plants. Nature 1989; 342:76-78.
15. Ma JK, Hiatt A, Hein M, et al. Generation and assembly of secretory antibodies in plants. Science 1995; 268:716-719.
16. Nawrath C, Poirier Y, Sommerville C. Targeting of the hydroxybutyrate biosynthetic pathway to the plastids of Arabidopsis thaliana results in high levels of polymer accumulation. Proc Natl Acad Sci USA 1994; 91:12760-12764.
17. Clemens JD, Sack DA, Harris JR, et al. Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet 1990; 335:270-273.
18. Clemens JD, el-Morshidy S. Construction of a potential live oral bivalent vaccine for typhoid fever and cholera-Escherichia coli-related diarrheas. Infect Immunol 1984; 46:564-569.
19. Scerpella EG, Sanchez JL, Mathewson JJ, et al. Safety, immunogenicity, and protective efficacy of whole cell/recombinant B subunit (WC/rBS) oral cholera vaccine. J Travel Med 1995;2:22-27.
20. Jiang X, Wang M, Graham DY, Estes MK. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol 1992; 66:6527-6532.
21. Prasad BVV, Rothnagel R, Jiang X, Estes MK. Three-dimensional structure of baculovirus-expressed Norwalk virus capsids. J Virol 1994; 68:5117-5125.
22. Mason HS, Ball J, Shi J, et al. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc Natl Acad Sci 1996; in press.
23. Eighth International Congress of Mucosal Immunology. Clinical Immunology and Immunopathology. San Diego, CA: 1995; 76.
24. Mason HS, Lam DMK, Arntzen CJ. Expression of hepatitis B surface antigen in transgenic plants. Proc Nat Acad Sci USA 1992;89:11745-11749.
25. Thanavala Y, Yang Y-F, Lyons P, et al. Immunogenicity of transgenic plant-derived hepatitis B surface antigen. Proc Nat Acad Sci USA 1995; 92:3358-3361.
26. Crawford SE, Labbe M, Cohen J, et al. Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells. J Virol 1994; 68:5945-5952.
27. May GD, Afza R, Mason HS, et al. Generation of transgenic banana (Musa acuminata) plants via Agrobacerium-mediated transformation. Biotechnology 1995;13:486-492.